Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016 (2016), Article ID 2548689, 6 pages
http://dx.doi.org/10.1155/2016/2548689
Research Article

Coupling of the Functional Stability of Rat Myocardium and Activity of Lipid Peroxidation in Combined Development of Postinfarction Remodeling and Diabetes Mellitus

Federal State Budgetary Scientific Institution “Research Institute for Cardiology”, 111a Kievskaya Street, Tomsk 634012, Russia

Received 1 July 2015; Revised 28 September 2015; Accepted 21 October 2015

Academic Editor: Gregory Giamouzis

Copyright © 2016 S. A. Afanasiev et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Garcia, P. M. McNamara, T. Gordon, and W. B. Kannell, “Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow up study,” Diabetes, vol. 23, no. 2, pp. 105–111, 1974. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Boudina, S. Sena, H. Theobald et al., “Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins,” Diabetes, vol. 56, no. 10, pp. 2457–2466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Buchanan, P. K. Mazumder, P. Hu et al., “Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity,” Endocrinology, vol. 146, no. 12, pp. 5341–5349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-Y. Li, X. Yang, A. F. Ceylan-Isik, M. Du, N. Sreejayan, and J. Ren, “Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch,” Diabetologia, vol. 49, no. 6, pp. 1434–1446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ziegelhöffer, I. Waczulíková, M. Ferko, L. Šikurová, J. Mujkošová, and T. Ravingerová, “Involvement of membrane fluidity in endogenous protective processes running on subcellular membrane systems of the rat heart,” Physiological Research, vol. 61, supplement 2, pp. S11–S21, 2012. View at Google Scholar · View at Scopus
  6. B. Ziegelhöffer-Mihalovičová, I. Waczulíková, L. Šikurová, J. Styk, J. Čársky, and A. Ziegelhöffer, “Remodelling of the sarcolemma in diabetic rat hearts: the role of membrane fluidity,” Molecular and Cellular Biochemistry, vol. 249, no. 1-2, pp. 175–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. T. Roe, M. Frisk, and W. E. Louch, “Targeting cardiomyocyte Ca2+ homeostasis in heart failure,” Current Pharmaceutical Design, vol. 21, no. 4, pp. 431–448, 2014. View at Publisher · View at Google Scholar
  8. R. R. Lamberts, N. Hamdani, T. W. Soekhoe et al., “Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium,” The Journal of Physiology, vol. 582, no. 2, pp. 695–709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. V. Popov, D. S. Kondratieva, S. A. Afanasiev, and B. N. Kozlov, “Changes in mechanical restitution of isolated myocardium in patients with ischemic heart disease and diabetes mellitus,” Frontiers in Pathology and Genetics, vol. 1, no. 3, pp. 25–29, 2013. View at Google Scholar
  10. I. A. Hobai and B. O'Rourke, “Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure,” Circulation, vol. 103, no. 11, pp. 1577–1584, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Lehnart, L. S. Maier, and G. Hasenfuss, “Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart,” Heart Failure Reviews, vol. 14, no. 4, pp. 213–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Lou, V. V. Fedorov, A. V. Glukhov, N. Moazami, V. G. Fast, and I. R. Efimov, “Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure,” Circulation, vol. 123, no. 17, pp. 1881–1890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Köhler, C. M. Sag, and L. S. Maier, “Reactive oxygen species and excitation-contraction coupling in the context of cardiac pathology,” Journal of Molecular and Cellular Cardiology, vol. 73, pp. 92–102, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tsutsui, S. Kinugawa, and S. Matsushima, “Oxidative stress and heart failure,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 6, pp. H2181–H2190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Wu, C.-X. Gong, X. Meng, and Q.-L. Yang, “Correlation between blood glucose fluctuations and activation of oxidative stress in type 1 diabetic children during the acute metabolic disturbance period,” Chinese Medical Journal, vol. 126, no. 21, pp. 4019–4022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Chen, W.-L. Shen, X.-H. Wang et al., “Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 10, pp. 910–916, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ravingerová, A. Adameová, J. Matejíková et al., “Subcellular mechanisms of adaptation in the diabetic myocardium: relevance to ischemic preconditioning in the nondiseased heart,” Experimental & Clinical Cardiology, vol. 15, no. 4, pp. 68–76, 2010. View at Google Scholar
  18. I. Waczulíková, A. Ziegelhöffer, Z. Országhová, and J. Čarsky, “Fluidising effect of resorcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca2+ overload,” Journal of Physiology and Pharmacology, vol. 53, no. 4, part 2, pp. 727–739, 2002. View at Google Scholar · View at Scopus
  19. D. S. Kondrat'eva, S. A. Afanas'ev, and S. V. Popov, “Expression of Ca2+-ATPase in sarcoplasmic reticulum in rat cardiomyocytes during experimental postinfarction cardiosclerosis and diabetes mellitus,” Bulletin of Experimental Biology and Medicine, vol. 156, no. 6, pp. 750–752, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Satoh, T. Sato, M. Shimada, K. Yamada, and Y. Kitada, “Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ventricular muscles of rats with diabetic cardiomyopathy,” Journal of Pharmacology and Experimental Therapeutics, vol. 298, no. 3, pp. 1161–1166, 2001. View at Google Scholar · View at Scopus
  21. M. A. Usacheva, E. V. Popkova, E. A. Smirnova, V. A. Saltykova, and L. M. Belkina, “Adaptation of the cardiovascular system to postinfarction cardiosclerosis in rats with congenital adrenoreactivity of the myocardium,” Bulletin of Experimental Biology and Medicine, vol. 144, no. 6, pp. 775–779, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. D. V. Vassallo, E. Q. Lima, P. Campagnaro, A. N. Faria, and J. G. Mill, “Mechanisms underlying the genesis of post-extrasystolic potentiation in rat cardiac muscle,” Brazilian Journal of Medical and Biological Research, vol. 28, no. 3, pp. 377–383, 1995. View at Google Scholar · View at Scopus
  23. E. N. Korobeinikova, “Modification of the definition of lipid peroxidation products in the reaction with thiobarbituric acid,” Laboratory Work, no. 7, pp. 8–10, 1989. View at Google Scholar
  24. J. L. Bolland and H. P. Koch, “The course of antioxidant reaction in polyisoprenes and allied compounds. Part IX. The primary thermal oxidation product of ethyl linoleate,” Journal of the Chemical Society, no. 7, pp. 445–447, 1945. View at Google Scholar · View at Scopus
  25. J. Inserte, D. Garcia-Dorado, V. Hernando, I. Barba, and J. Soler-Soler, “Ischemic preconditioning prevents calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion,” Cardiovascular Research, vol. 70, no. 2, pp. 364–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Sniecinski and H. Liu, “Reduced efficacy of volatile anesthetic preconditioning with advanced age in isolated rat myocardium,” Anesthesiology, vol. 100, no. 3, pp. 589–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Tanonaka, K. Motegi, T. Arino, T. Marunouchi, N. Takagi, and S. Takeo, “Possible pathway of Na+ flux into mitochondria in ischemic heart,” Biological and Pharmaceutical Bulletin, vol. 35, no. 10, pp. 1661–1668, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. E. Lehnart, X. H. T. Wehrens, A. Kushnir, and A. R. Marks, “Cardiac ryanodine receptor function and regulation in heart disease,” Annals of the New York Academy of Sciences, vol. 1015, pp. 144–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Palomeque, M. V. Petroff, L. Sapia, O. A. Gende, C. Mundiña-Weilenmann, and A. Mattiazzi, “Multiple alterations in Ca2+ handling determine the negative staircase in a cellular heart failure model,” Journal of Cardiac Failure, vol. 13, no. 2, pp. 143–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. K. Misra, M. Sarwat, P. Bhakuni, R. Tuteja, and N. Tuteja, “Oxidative stress and ischemic myocardial syndromes,” Medical Science Monitor, vol. 15, no. 10, pp. RA209–RA219, 2009. View at Google Scholar · View at Scopus
  31. T. I. Rebrova, D. S. Kondrat'eva, S. A. Afanas'ev, and E. I. Barzakh, “Activity of lipid peroxidation and functional state of the myocardium in remodeling of rat heart after experimental myocardial infarction,” Kardiologiia, vol. 47, no. 6, pp. 41–45, 2007. View at Google Scholar · View at Scopus
  32. C. Schneider, “An update on products and mechanisms of lipid peroxidation,” Molecular Nutrition & Food Research, vol. 53, no. 3, pp. 315–321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Ardehali, H. N. Sabbah, M. A. Burke et al., “Targeting myocardial substrate metabolism in heart failure: potential for new therapies,” European Journal of Heart Failure, vol. 14, no. 2, pp. 120–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Doenst, T. D. Nguyen, and E. D. Abel, “Cardiac metabolism in heart failure: implications beyond ATP production,” Circulation Research, vol. 113, no. 6, pp. 709–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. V. Zima, J. Kockskämper, and L. A. Blatter, “Cytosolic energy reserves determine the effect of glycolytic sugar phosphates on sarcoplasmic reticulum Ca2+ release in cat ventricular myocytes,” Journal of Physiology, vol. 577, no. 1, pp. 281–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Nawata, N. Takahashi, T. Ooie, K. Kaneda, T. Saikawa, and T. Sakata, “Cardioprotection by streptozotocin-induced diabetes and insulin against ischemia/reperfusion injury in rats,” Journal of Cardiovascular Pharmacology, vol. 40, no. 4, pp. 491–500, 2002. View at Publisher · View at Google Scholar · View at Scopus